Lipid-lowering guidelines (4)
PREVENTION of 10 clinically significant cardio-vascular events (p=0.02)
SAVING of 4 lives (p=0.204)
SAVINGS of $53,000 in hospital costs
Treatment with pravastatin of 100 PBS-eligible patients derived from a meta-analysis of PLAC I and PLAC II (over a three-year period) would have resulted in:
Source: Multiple trials data; analysis Bristol-Myers Squibb